Wolff Wiese Magana’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.8K Hold
15
﹤0.01% 610
2026
Q1
$4.39K Hold
15
﹤0.01% 626
2025
Q4
$5.26K Hold
15
﹤0.01% 570
2025
Q3
$4.85K Buy
15
+5
+50% +$1.55K ﹤0.01% 601
2025
Q2
$3.89K Sell
10
-5
-33% -$2.01K ﹤0.01% 609
2025
Q1
$6.53K Hold
15
﹤0.01% 493
2024
Q4
$5.53K Sell
15
-15
-50% -$6.28K ﹤0.01% 529
2024
Q3
$15.6K Buy
30
+14
+88% +$7.48K 0.01% 355
2024
Q2
$8.67K Hold
16
0.01% 345
2024
Q1
$8.3K Hold
16
0.01% 318
2023
Q4
$7.54K Hold
16
0.01% 320
2023
Q3
$6.97K Buy
16
+3
+23% +$1.36K 0.01% 390
2023
Q2
$5.78K Buy
13
+2
+18% +$923 ﹤0.01% 424
2023
Q1
$5.06K Sell
11
-4
-27% -$1.9K ﹤0.01% 424
2022
Q4
$7.7K Sell
15
-359
-96% -$182K 0.01% 357
2022
Q3
$170K Buy
374
+3
+0.8% +$1.44K 0.14% 122
2022
Q2
$179K Buy
371
+65
+21% +$32.2K 0.13% 125
2022
Q1
$150K Buy
306
+76
+33% +$34.7K 0.1% 144
2021
Q4
$107K Sell
230
-107
-32% -$45K 0.07% 195
2021
Q3
$126K Buy
337
+90
+36% +$34.2K 0.09% 169
2021
Q2
$94K Buy
247
+76
+44% +$29K 0.07% 201
2021
Q1
$61K Sell
171
-8
-4% -$2.57K 0.05% 245
2020
Q4
$57K Buy
+179
New +$54.9K 0.05% 244

Other funds holding ELV

Wolff Wiese Magana's ELV Position: Q2 2026 in Review

Wolff Wiese Magana held its Elevance Health (ELV) position steady in Q2 2026 at 15 shares worth $5.8K. The position accounts for ﹤0.01% of the portfolio, ranked #610.

Wolff Wiese Magana first reported a position in ELV in Q4 2020 and has held it in 23 quarters since. The position peaked at $179K in Q2 2022. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wolff Wiese Magana held 15 shares of Elevance Health worth $5.8K as of Q2 2026.
  • Wolff Wiese Magana left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #610 holding.
  • Wolff Wiese Magana first reported a position in Elevance Health in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Elevance Health position peaked at $179K in Q2 2022.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.